Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
暂无分享,去创建一个
Meilan K. Han | F. Martinez | K. Flaherty | E. White | D. O’Dwyer | B. Moore | J. Erb-Downward | G. Huffnagle | C. Wilke | R. Dickson | S. Murray | M. Salisbury | M. Xia | S. Gurczynski | N. Falkowski | S. Ashley | K. Arnold | Katy C. Norman | M. Han | Meng Xia
[1] A. Morris,et al. The Lung Microbiome in Hematopoietic Stem Cell Transplant. Where the Money Lies. , 2018, American journal of respiratory and critical care medicine.
[2] D. O’Dwyer,et al. Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation , 2018, American journal of respiratory and critical care medicine.
[3] J. Erb-Downward,et al. The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity , 2018, American journal of respiratory and critical care medicine.
[4] E. Abraham,et al. Metformin reverses established lung fibrosis in a bleomycin model , 2018, Nature Medicine.
[5] D. Lederer,et al. Idiopathic Pulmonary Fibrosis. , 2018, The New England journal of medicine.
[6] Xinran Liu,et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function , 2017, Nature Medicine.
[7] B. Moore,et al. Bone Marrow Transplant Induced Alterations in Notch Signaling Promote Pathologic Th17 Responses to γ-Herpesvirus Infection , 2017, Mucosal Immunology.
[8] Yves A. Lussier,et al. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.
[9] Zachary D. Kurtz,et al. Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ , 2017, ERJ Open Research.
[10] Athol U. Wells,et al. Host‐Microbial Interactions in Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.
[11] C. Hogaboam,et al. Host-Microbial Interactions: Idiopathic Pulmonary Fibrosis in Technicolor. , 2017, American journal of respiratory and critical care medicine.
[12] P L Molyneaux,et al. Integrierte Analyse von Patienten-Genen und respiratorischem Mikrobiom , 2017, Pneumologie.
[13] L. Richeldi,et al. New treatment directions for IPF: current status of ongoing and upcoming clinical trials , 2017, Expert review of respiratory medicine.
[14] R. Chambers,et al. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis , 2017, American journal of respiratory cell and molecular biology.
[15] F. Martinez,et al. The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes , 2017, Scientific Reports.
[16] M. Moffatt,et al. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis , 2017, Respiratory Research.
[17] B. Moore,et al. Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis , 2016, Mucosal Immunology.
[18] D. O’Dwyer,et al. Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[19] D. Lynch,et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. , 2016, American journal of respiratory and critical care medicine.
[20] Benjamin H Singer,et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome , 2016, Nature Microbiology.
[21] A. Sichelstiel,et al. Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies. , 2016, American journal of respiratory and critical care medicine.
[22] W. R. Wikoff,et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype , 2016, Nature Microbiology.
[23] F. Martinez,et al. The Microbiome and the Respiratory Tract. , 2016, Annual review of physiology.
[24] Y. Iwakura,et al. Bone marrow transplantation alters lung antigen presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection , 2015, Mucosal Immunology.
[25] R. Neubig,et al. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. , 2015, The American journal of pathology.
[26] Elissa Murphy,et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.
[27] K. Gibson,et al. The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it? , 2014, American journal of respiratory and critical care medicine.
[28] F. Martinez,et al. The role of the microbiome in exacerbations of chronic lung diseases , 2014, The Lancet.
[29] Meilan K. Han,et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. , 2014, The Lancet. Respiratory medicine.
[30] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[31] Ivana V. Yang,et al. Muc5b is required for airway defence , 2013, Nature.
[32] Gordon Cooke,et al. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.
[33] Naftali Kaminski,et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.
[34] P. Chambon,et al. Homeostasis in Intestinal Epithelium Is Orchestrated by the Circadian Clock and Microbiota Cues Transduced by TLRs , 2013, Cell.
[35] F. Martinez,et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[36] E. Chilvers,et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial , 2012, Thorax.
[37] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[38] J. Behr. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[39] J. Renauld,et al. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. , 2011, American journal of respiratory and critical care medicine.
[40] Thomas A. Wynn,et al. Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.
[41] T. Wynn,et al. Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive Pathogens , 2011, PLoS pathogens.
[42] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[43] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[44] V. Aidinis,et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[45] H. Takano,et al. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. , 2008, American journal of respiratory cell and molecular biology.
[46] A. Mehta,et al. Lung transplantation for idiopathic pulmonary fibrosis. , 2007, The Annals of thoracic surgery.
[47] I. Stříž,et al. Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. , 2006, Tissue antigens.
[48] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[49] T. Moore,et al. Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1 , 2001, The Journal of Immunology.
[50] D. Anthony,et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. , 2001, The Journal of clinical investigation.
[51] P. Zabel,et al. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. , 1998, American journal of respiratory and critical care medicine.